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Abstract Mammalian sensory neurons express a voltage-gated
sodium channel named SNS. Here we report the identification of
an SNS transcript (SNS-A) that contains an exact repeat of
exons 12, 13 and 14 encoding a partial repeat of domain II.
Because the exons 12^14 are present in single copies in genomic
DNA, the SNS-A transcript must arise by trans-splicing. Nerve
growth factor, which regulates pain thresholds, and the
functional expression of voltage-gated sodium channels increases
the levels of the SNS-A transcript several-fold both in vivo and in
vitro as measured by RNase protection methods, as well as
RT-PCR. These data demonstrate a novel regulatory role for the
nerve growth factor and are the first example of trans-splicing in
the vertebrate nervous system.
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1. Introduction
Voltage-gated sodium channels play an essential role in the
generation and propagation of action potentials [1]. In adult
rat dorsal root ganglia (DRG) neurons in culture, large diam-
eter cells express tetrodotoxin-sensitive (TTXs) sodium cur-
rents, whilst small neurons also express tetrodotoxin-insensi-
tive (TTXi) currents [2^5]. A TTXi sodium channel K-subunit
named sensory neuron speci¢c (SNS) accounts for the TTXi
sodium currents described in small diameter sensory neurons
[6,7].
Transcriptional regulation of sodium channel expression by
nerve growth factor (NGF) has been demonstrated [8]; NGF
application has been shown to cause dramatic decreases in
thermal, chemical and mechanical thresholds of pain percep-
tion in animal models [9]. It seemed plausible that transcrip-
tional regulation of sodium channel expression by NGF might
play a role in the development of NGF-mediated hyperalge-
sia. We therefore examined the levels of the SNS K-subunit in
in£ammatory models and in NGF-treated neurons in culture.
We found a small e¡ect on the total amount of SNS mRNA
consistent with earlier studies [10]. In contrast, there was a
dramatic e¡ect of NGF on a splice variant of SNS both in
vitro and in vivo. Sequence analysis showed that the variant,
named SNS-A, contains an identical repeat of three exons,
encoding four transmembrane regions of domain II, including
a partial S4 domain that comprises a voltage sensor. The
splice variant is induced several-fold by NGF. Because no
exon duplications are present between exons 11 and 15 in
either mouse or rat genomes, the SNS variant must arise by
a form of trans-splicing, a phenomenon never previously ob-
served in a vertebrate structural gene.
2. Materials and methods
Southern blots, Northern blots and DNA sequencing were carried
out as previously described in detail [11].
3. Detection and quantitation of SNS and SNS-A
Adult rat DRG neurons were cultured in the presence of
NGF (50 ng/ml) and cytosine-L-D-arabinofuranoside (10 WM)
for the ¢rst 3 days. Cultures were then supplemented with
NGF (50 ng/ml) or grown in the absence of NGF and pres-
ence of rabbit anti-NGF antiserum (Sigma) for 7 days. Alter-
natively, 2 day old rats were treated with 2 Wg NGF i.p. 24 h
before DRG removal. Total RNA was extracted from the
culture or whole DRG. SNS-A was detected by RT-PCR
and quantitated with RNase protection assays. 5 Wg total
RNA from the DRG neurons cultured with or without
NGF were treated with DNase I and cDNA was synthesised
with Superscript reverse transcriptase using random hexamer
primers in a total volume of 20 Wl. 1 Wl of the reverse tran-
scribed solution was used for PCR (32 cycles: 94‡C, 1 min:
55‡C, 1 min: 72‡C, 1 min) in the presence of the primer pairs
speci¢c for splice variant SNS, total SNS and CGRP. Primer
sequences used in the PCR are as follows: SNS-A (393 bp):
5P-CAGCTTCGCTCAGAAGTA-3P, 5P-TGCCCTGTAGTG-
TGCAGT-3P : total SNS (168 bp) 5P-AGCACGGTGGAC-
TGCCCGGA-3P, 5P-GCGCACCTGCCAGCCTGT-3P : CG-
RP (223 bp), 5P-GGTGTGGTGAAGGACAAC-3P, 5P-TCA-
TAGGGAGAAGGG-3P.
L-27 primers were added to the PCR reaction six cycles
after the start. Each PCR experiment was carried out at least
four times and gave identical results. RNase protection assays
were performed as previously described [10]. Brie£y, 5 Wg total
RNA from the DRG neurons cultured with or without NGF
was hybridised with 32P-labelled cRNA probe speci¢c for to-
tal SNS, splice variant SNS, cyclophilin, and CGRP in the
presence of 80% formamide at 45‡C for 12 h. Each hybrid-
FEBS 21597 22-2-99
0014-5793/99/$19.00 ß 1999 Federation of European Biochemical Societies. All rights reserved.
PII: S 0 0 1 4 - 5 7 9 3 ( 9 9 ) 0 0 1 2 6 - X
*Corresponding author. Fax: (44) (171) 380 7800.
E-mail: j.wood@ucl.ac.uk
1The first two authors contributed equally to this work.
Abbreviations: DRG, dorsal root ganglia; NGF, nerve growth factor;
SNS, sensory neuron specific; TTXi, tetrodotoxin-insensitive; TTXs,
tetrodotoxin-sensitive
FEBS 21597 FEBS Letters 445 (1999) 177^182
isation reaction was treated with 20 Wg/ml RNase A and 1 Wg/
ml RNase T1 at 33‡C for 30 min. The reaction was stopped
by proteinase K, extracted with phenol/chloroform, precipi-
tated with ethanol and redissolved in 10 Wl RNA loading
bu¡er. The protected bands were analysed on a denaturing
polyacrylamide/urea gel. Scanned images were quantitated us-
ing the public domain NIH image programme written by W.
Rasband and available from the internet by anonymous ftp
from zippy.nimh.nih.gov. The 359 bp probe for total SNS
mRNA was derived from an SphI fragment in the 3P untrans-
lated region of SNS and SNS-A. A probe that distinguished
SNS (373 bp) from the SNS-A variant of 393 bp was gener-
ated from the PCR product generated using primers 24 and 26
(see Fig. 2). The CGRP probe of 223 bp comprised part of
CGRP exons 5 and 6. The cyclophilin probe comprises 300 bp
of the coding sequence.
4. Results
4.1. Identi¢cation of an SNS splice variant
Sequencing of cDNA clones from a Sprague Dawley oligo
dT- primed cDNA library encoding SNS sodium channels led
to the identi¢cation of a novel K-subunit transcript named
SNS-A (one in six of the full length positive clones isolated)
that contained a 525 bp insert at position 1755 in interdomain
region 1 (ID1). Sequencing of this insert demonstrated that it
comprised an exact repeat of part of ID1 and the S1^3 and
part of the S4 domains present in domain 2, whilst the re-
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Fig. 1. A: genomic structure of SNS domain II. A restriction map of the genomic locus containing exons 11^15 of the sns gene in either
mouse 129/SV or Sprague-Dawley rat genomic libraries is shown. The region was mapped with ApaI (A), BamHI (B), KpnI (K), EcoRI (R),
SalI (SI), SmaI (Sm), XbaI (X) and XhoI (Xh) restriction enzymes and analysed by cross hybridisation studies. B: Structure of SNS and SNS-
A and location of PCR primers. A schematic drawing of the location of the repeat present in SNS-A (a 525 bp insert at position 1755 in ID1)
and its relation to the normal domain structure of SNS is shown. The location of the PCR primers shown in the Section 2 used to identify the
splice variant and to generate an RNase protection probe which will distinguish normal and spliced transcripts is shown.
A.N. Akopian et al./FEBS Letters 445 (1999) 177^182178
mainder of the clone including the 5P and 3P UTRs corre-
sponded exactly to the sequence of the native transcript
(Fig. 1). The exon-intron structure and splice donor and ac-
ceptor sites for sns have previously been described [11] and the
insert corresponds precisely to a repeat of exons 12, 13 and
14. We therefore examined the genomic structure of the sns
gene in mouse and rat, in order to detect the existence of any
repeated exons. Using a combination of sequencing and
Southern blotting with overlapping clones that are shown in
Fig. 1, we carefully analysed the genomic organisation of
exons 12, 13 and 14 that encode the apparent sequence repeat
[11].
In Fig. 1A, a map of the locus of the rat genomic sns clone
is shown. Genomic rat DNA in V-¢x II was digested with
EcoRI and either EcoRI with SalGI, or EcoRI and NotI.
The (NotI and SalGI sites are adjacent to each other in the
lambda ¢x II polylinker). The digests were Southern-blotted
and hybridised with cDNA fragments of exon-speci¢c probes.
A single EcoRI 2.1 kb digestion product hybridised with the
exon 11 speci¢c clone. A 1.5 kb EcoRI fragment hybridised
with probes for exons 11, 12 and 13, but not exons 11 or
exons 13 and 14. This 1.5 kb fragment must therefore contain
exon 12 alone. Hybridisation of the V5 and V12 clones with
probes for exons 13 and 14, exons 11, 12 and 13 and an exon
11 speci¢c probe shows that the 6.8 kb fragment contains
exons 13 and 14. V12 contains exon 14 but not exons 11,
12 and 13. There is no exon duplication for 6.8 kb down-
stream of exon 14. Exon 15 was localised by hybridisation
with probes for exons 11^15. A 5.7 kb EcoRI fragment of
V12 contains only exon 15. Taken together these data (not
shown) demonstrate that there is no duplication of exons
12^14 between exons 11 and 15. Similar data were obtained
using mouse 129/sv genomic DNA.
We analysed Sprague-dawley rat genomic DNA by South-
ern blotting to determine whether exons 12^14 might exist in
the genome outside the locus covered by the genomic clones.
To discount any possible rearrangement of DNA in DRG, we
analysed DNA extracted from both DRG and brain, re-
stricted with one of the three enzymes (Fig. 2).
The data presented in Fig. 2 con¢rm the fact that exons 12^
14 encoding the putative repeat are only present in single
copies in the genome. The possibility that the SNS-A tran-
script could be a cloning artefact was tested by examining the
occurrence of SNS-A like transcripts in RNA extracted from
DRG. We devised both a PCR strategy and an RNase pro-
tection protocol to examine the occurrence of the splice var-
iant transcript in both cDNA and RNA derived from DRG
sensory neurons (Fig. 3).
Fig. 1B demonstrates the primers that were used to distin-
guish between the wild-type SNS and variant SNS-A chan-
nels. Because of their orientations, primers 24 (CTGCCCT-
GTAGTGTGAGT) and 26 (CAGCTTCGCTCAGAAGTA)
will only produce a PCR product of a size of 393 bp with the
splice variant, but not with the wild-type transcript. We se-
quenced the PCR product to con¢rm that the sequence cor-
responds to SNS-A. Using the PCR product from these
primers, RNase protection probes were also generated that
would give distinct size products of 373 bp for SNS mRNA
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Fig. 2. Southern blots of rat DNA from DRG or brain show that exons 12^14 are not duplicated. Using three restriction enzymes and exon
speci¢c probes (see Figure 1), genomic DNA digests from DRG and brain (right panel) were analysed by Southern blotting. A 1 kb ladder is
marked on the left of the ¢gure. The sizes of restricted bands are:
Exon 11 Exon 12 Exon 13 Exon 14 Exon 15
EcoRI 2.1 1.5 6.8 6.8 5.7
BamHI 15 15 15 15 2
ApaI 11 6.1 12.5 12.5 0.7 and 2.0
demonstrating the presence of single copies of the probed exons.
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and 393 bp for SNS-A mRNA. Using these two approaches,
it can be seen (Fig. 3) that the splice variant occurs not only in
DRG-derived cDNA but also in RNA extracted from these
cells, precluding the possibility that SNS-A represents a clon-
ing artefact.
4.2. NGF regulation of SNS-A expression
The e¡ect of NGF on the levels of expression of SNS and
the SNS-A transcript was ¢rst examined using adult DRG
neurons grown in culture. CGRP was used as a positive con-
trol to examine the e¡ect of NGF on transcript levels which
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Fig. 3. NGF regulation of SNS-A expression. A: RT-PCR analysis of SNS and SNS-A. RNA extracted from adult rat DRG neurons grown
in the absence (3) or presence (+) of NGF for one week was used to generate random primed cDNA that was subjected to RT-PCR as de-
scribed in 2. In the absence of reverse transcriptase, no PCR products were generated (3RT). In the presence of reverse transcriptase (+RT),
levels of the control ribosomal transcript L-27 are similar in + and 3NGF samples. The levels of CGRP and the sodium channel splice variant
SNS-A are clearly up-regulated, whilst the total amount of SNS transcript is little a¡ected by variations in NGF treatment. B: In vivo studies.
Male and female rats were treated with 0.5 Wg/g i.p. NGF for 24 h and DRG was removed and RNA extracted from control and experimental
litter mates. In the absence of reverse transcriptase, no PCR products were generated (3RT). In the presence of reverse transcriptase (+RT),
levels of the control cyclophilin transcript are similar in + and 3NGF samples. The levels of CGRP and the sodium channel splice variant
SNS-A are clearly up-regulated to similar levels, whilst the total amount of SNS transcript is little a¡ected by NGF treatment in four out of
four experiments. C and D: RNase protection analysis of SNS and SNS-A levels in NGF-treated DRG neurons. Using the probe derived from
the PCR products, generated using primers 24 and 26 (see Figure 1B), and probes derived from the common 3P region of SNS and SNS-A, the
e¡ect of NGF on the levels of the transcripts was investigated. C: The levels of total SNS transcripts are shown to be slightly up-regulated in
the presence of NGF, when normalised to the levels of cyclophilin mRNA. D: The 2 products of RNase protection are shown. The larger 393
bp protected band representing the level of SNS-A transcripts is strongly up-regulated by NGF treatment, as is the mRNA encoding CGRP
(D). Cyclophilin levels are little changed and scanned bands are normalised to cyclophilin to provide estimates of the level of NGF induction
of the transcripts shown.
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are known to be NGF-regulated. Cyclophilin and L-27 are
ubiquitously expressed genes, which are not regulated in ex-
pression by NGF and we therefore normalised the levels of
protected transcripts in RNase protection experiments to cy-
clophilin or to the ribosomal protein L-27 transcript to obtain
semi-quantitative data on NGF induction [12].
RT-PCR was ¢rst used to examine the relative levels of
SNS and SNS-A in DRG-derived cDNA. As can be seen in
Fig. 3A, there is a dramatic increase in SNS-A levels on NGF
treatment. We carried out similar experiments in neonatal
rats, where we found a similar level of increase of both splice
variant and CGRP transcripts in systemic treatment with
NGF (Fig. 3B). In contrast to the in vitro studies, anti-
NGF antisera had no e¡ect on baseline levels of CGRP and
SNS-A, probably because the time course of the in vivo ex-
periment was only 24 h. In order to quantitate the induction
of the splice variant by NGF, we carried out RNase protec-
tion experiments. After 7 days in culture, there was a 6-fold
alteration in the levels of CGRP mRNA, whilst cyclophilin
levels were unaltered. Interestingly, the level of mRNA encod-
ing the splice variant SNS-A increased 8-fold, whilst the total
level of mRNA showed little change (15^20%) on NGF addi-
tion (Fig. 3C,D). Western blotting has already demonstrated
that there is a small increase in immunoreactive SNS on NGF
treatment of adult DRG neurons, whilst total mRNA levels
are up-regulated to a limited extent (about 20%) [10].
The regulation of sodium channel activity in sensory neu-
rons has been linked to altered pain thresholds [18]. NGF is
known to cause peripheral hyperalgesia [15]. NGF has been
shown to in£uence the splice choice in PC12 cells, causing
altered expression of both beta-amyloid precursors and agrin
splice variants [13,14]. Post-transcriptional regulation of po-
tassium channel expression by NGF has been observed using
Western blots combined with RNase protection in PC12 cells
[15]. Here, administration of NGF led to a 6-fold increase in
protein and channel density, but the level of mRNA transcript
was apparently una¡ected, although the possibility that alter-
native splicing occurred was not explored. Alternative splicing
of many VGSCs, sometimes leading to channels with distinct
functional properties has been described [16].
The mechanism that gives rise to the NGF-induced variant
SNS-A is not yet understood. The evidence that the exon 12^
14 repeat present in the mRNA transcript is not present in
genomic DNA is good, suggesting that some from of trans-
splicing must occur. Splicing involves the actions of small
nuclear RNAs and over 50 protein components that form
spliceosomes that act with remarkable ¢delity to excise in-
tronic sequences. Trans-splicing has been observed in yeast
[17] in trypanosomes [18] and in Caenorhabditis elegans [19].
There is good evidence that mammalian cells are able to trans-
splice RNA derived from studies of mRNA from simple eu-
karyotes, or viral transcripts encoding SV40 T-antigen in nu-
clear injected mammalian cell lines and nuclear extracts
[20,21]. There is also evidence for trans-splicing in the immune
system. Germ line transcripts from Ig heavy chain loci precede
the occurrence of isotype switching. A reverse transcriptase-
PCR approach detected human chimeric Ig germ line mRNA
transcripts in human B-cells stimulated with IL-4 [22]. Se-
quence analysis revealed that all of these chimeric Ig germ
line transcripts represented the exons from one Ig locus
spliced to the CH exons from another locus using consensus
splicing donor and acceptor sites, indicating that they were
generated through splicing machinery. Similarly a CAM Ki-
nase II transcript present in islets of Langerhans has been
proposed to arise by trans-splicing [23]. The mechanisms in-
volved in cis- and trans-splicing may be closely related. A
family of Serine-Arginine rich RNA binding proteins known
as SR proteins have been shown to play a critical role in the
formation of active spliceosomes. Interestingly, peripheral
nerve crush has been shown to regulate the level of expression
of one such protein, Srp20 [24].
The functional signi¢cance of NGF-mediated regulation of
SNS splice variants in nociception is not yet clear. Attempts
to express the SNS-A variant in a functional form in heterol-
ogous expression systems have failed. However, the apparent
lack of activity of SNS-A does not preclude an e¡ect on
neuronal excitability in vivo. E¡ects of the SNS-A splice var-
iant on channel tra⁄cking, the subcellular localisation of the
functional SNS channel or the half life of functional channels,
although not apparent in dissociated tissue culture, may reg-
ulate nociceptive thresholds in vivo.
In summary, we have demonstrated the existence of a novel
splice variant of SNS that contains a three exon repeat in
domain II, and encodes a translatable protein. NGF induces
the appearance of this splice variant in vitro and in vivo. The
only plausible explanation for the appearance of this tran-
script is trans-splicing. Although evidence for trans-splicing
using RT-PCR has been obtained in the mammalian immune
system and cell lines, the use of RNase protection in the
present study provides compelling evidence for the existence
of trans-spliced transcripts. The regulation of this event by
NGF identi¢es yet another locus of regulatory action for
the neurotrophins.
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